Geron (GERN) Debt Ratio (2011 - 2026)
Geron's (GERN) quarterly Debt Ratio came in at 0.22 in Q1 2026, up 6.28% year-on-year from 0.21 in Q1 2025, and up 7.07% quarter-over-quarter from 0.21 in Q4 2025.
Geron (GERN) Debt Ratio (2011 - 2026) Analysis & Trends
Geron has disclosed Debt Ratio across 8 years of filings, most recently posting 0.22 for Q1 2026.
- Debt Ratio for Q1 2026 came in at 0.22, up 6.28% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.22 (up 6.28% YoY), and the FY2025 annual result was 0.21, up 5.01% from the prior year.
- Debt Ratio came in at 0.22 for Q1 2026 at Geron, up from 0.21 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.27 in Q4 2022 to a low of 0.12 in Q1 2023.
- The 5-year median for Debt Ratio is 0.21 (2025), against an average of 0.2.
- Across the five-year window, Debt Ratio jumped 170.0% in 2022 and tumbled 52.16% in 2023, its largest moves.
- Geron's Debt Ratio stood at 0.27 in 2022, then declined by 22.54% to 0.21 in 2023, then dropped by 4.05% to 0.2 in 2024, then climbed by 5.01% to 0.21 in 2025, then gained by 7.07% to 0.22 in 2026.
- The last three Debt Ratio figures came in at 0.22 (Q1 2026), 0.21 (Q4 2025), and 0.21 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 0.18 |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Geron | 729,618.77 | 729,618.77 | - | 0.22 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.22 |
| Dec 31, 2025 | 0.21 |
| Sep 30, 2025 | 0.21 |
| Jun 30, 2025 | 0.21 |
| Mar 31, 2025 | 0.21 |
| Dec 31, 2024 | 0.20 |
| Sep 30, 2024 | 0.19 |
| Jun 30, 2024 | 0.19 |
| Mar 31, 2024 | 0.17 |
| Dec 31, 2023 | 0.21 |
| Sep 30, 2023 | 0.13 |
| Jun 30, 2023 | 0.12 |
| Mar 31, 2023 | 0.12 |
| Dec 31, 2022 | 0.27 |
| Sep 30, 2022 | 0.22 |
| Jun 30, 2022 | 0.21 |
| Mar 31, 2022 | 0.25 |
| Dec 31, 2021 | 0.22 |
| Sep 30, 2021 | 0.15 |
| Jun 30, 2021 | 0.14 |